Salicylate poisoning is a serious complication of aspirin overdose and is characterized by mixed respiratory alkalosis and increased anion gap metabolic acidosis.

Pathophysiology


  • Occurs with acute ingestion of >150 mg/kg. Doses >300 mg/kg are associated with severe toxicity, and >500 mg/kg are potentially lethal.
  • Dual mechanism of acid-base disturbance:
    • Respiratory Alkalosis (Early): Salicylates directly stimulate the medullary respiratory center, leading to hyperventilation and a primary respiratory alkalosis. This is the initial disturbance.
    • Anion Gap Metabolic Acidosis (Later): Salicylates uncouple oxidative phosphorylation in the mitochondria. This shifts cells to anaerobic metabolism, leading to the accumulation of lactate and ketoacids, causing a primary metabolic acidosis.
  • The classic picture is a mixed respiratory alkalosis and metabolic acidosis.
  • In young children, metabolic acidosis may be the dominant or only initial finding.

Clinical features


  • Early Symptoms: Nausea, vomiting, abdominal pain, and lethargy are common. Tinnitus (ringing in the ears) is a classic and early symptom.
  • Systemic Symptoms:
    • Hyperthermia/Fever: Due to uncoupling of oxidative phosphorylation, which generates heat. This is particularly common in children.
    • Tachypnea: Caused by direct stimulation of the respiratory center.
  • Severe Toxicity:
    • Altered Mental Status: Confusion, agitation, delirium, seizures, or coma can occur, often due to low glucose levels in the brain and cerebral edema.
    • Pulmonary Edema: Non-cardiogenic pulmonary edema can develop from direct lung toxicity.
    • Hypoglycemia: Can occur despite normal serum glucose due to low CNS glucose levels.

Diagnostics


Differential diagnostics


FeatureSalicylate (ASA) PoisoningAcetaminophen (APAP) PoisoningReye Syndrome
Classic HxOverdose (intentional/accidental)Intentional OD; chronic EtOH useChild after viral illness + ASA use
PathophysiologyUncouples ox-phos;
Resp center stim;
Direct ototoxicity
Glutathione depletion toxic metabolite (NAPQI) liver necrosisMitochondrial dysfunction fatty liver & encephalopathy
PresentationTinnitus, fever, hyperventilation, AMSAsymptomatic initially RUQ pain fulminant liver failureProfuse vomiting, delirium/coma, NO jaundice
Key Lab FindingMixed resp. alkalosis + metabolic acidosisMassive AST/ALT elevation (>1000s)Hyperammonemia, elevated LFTs, hypoglycemia
Antidote / TxIV Sodium Bicarbonate, HemodialysisN-acetylcysteine (NAC)Supportive care (manage ICP, hypoglycemia)
Buzzword”Mixed acid-base disorder""Rumack-Matthew nomogram""Child + virus + aspirin”
Link to original

Treatment


  • 1. Supportive Care (ABCDE Approach): Stabilize airway, breathing, and circulation.
    • Intravenous fluids are given for dehydration.
    • Glucose (Dextrose) should be administered, even if serum glucose is normal, to address potential CNS hypoglycemia.
    • Avoid intubation if possible. If necessary, hyperventilation must be maintained on the ventilator to prevent worsening acidosis, as a sudden rise in PaCO2 can be fatal.
  • 2. GI Decontamination:
    • Activated Charcoal: Can be given if the patient presents within 1-2 hours of ingestion to decrease absorption. Multiple doses may be considered for large or sustained-release ingestions.
  • 3. Enhanced Elimination:
    • IV Sodium Bicarbonate: This is the mainstay of treatment. It serves two purposes:
      • Alkalinizes the urine (to a pH of 7.5-8.0), which traps the ionized form of salicylic acid in the renal tubules, enhancing its excretion.
      • Alkalinizes the serum, which helps shift salicylate out of the central nervous system and into the plasma.
    • Potassium supplementation is often required, as hypokalemia can prevent effective urinary alkalinization.
  • 4. Hemodialysis:
    • Indications: Used for severe cases and is life-saving.
    • Criteria include: very high salicylate levels (>90-100 mg/dL), end-organ damage (e.g., seizures, cerebral edema, renal failure, pulmonary edema), severe acidosis (pH < 7.2), or failure of standard therapy.